Marie‐Hélène Soriani

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 800 citations

Medicine, Pharmacology, Pharmacotherapy +6

Brain computer interface with the P300 speller: Usability for disabled people with amyotrophic lateral sclerosis

Violaine Guy, Marie‐Hélène Soriani, Mariane Bruno et al. · Annals of Physical and Rehabilitation Medicine · 2017 · 123 citations

Life Sciences, Neurology, Neuroscience +17

Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial

Vincent Meininger, Angela Genge, Leonard H van den Berg et al. · The Lancet Neurology · 2017 · 85 citations · Full text

Life Sciences, Neurology, Neuroscience +10

Do patients having a decrease in SNAP amplitude during the course of MMN present with a different condition?

Émilien Delmont, Charles Benaïm, M. Launay et al. · Journal of Neurology · 2009 · 33 citations

Medicine, Clinical Sciences, Physical Examination +1

Safety, tolerability, and efficacy of fasudil in amyotrophic lateral sclerosis (ROCK-ALS): a phase 2, randomised, double-blind, placebo-controlled trial

Jan Christoph Koch, Andreas Leha, Helen Bidner et al. · The Lancet Neurology · 2024 · 29 citations · Full text

Life Sciences, Neurology, Neuroscience +11